Mirati Therapeutics, Inc.
MRTX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$162 | -$177 | -$185 | -$202 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | -$122 | -$144 | $0 | $0 |
| Stock-Based Comp. | $45 | $39 | $47 | $62 |
| Change in WC | -$23 | $12 | -$49 | $17 |
| Other Non-Cash | $117 | $138 | -$5 | -$6 |
| Operating Cash Flow | -$144 | -$131 | -$190 | -$129 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$0 | -$1 |
| Net Acquisitions | $62 | -$16 | -$195 | -$60 |
| Inv. Purchases | -$342 | -$237 | -$127 | -$237 |
| Inv. Sales/Matur. | $280 | $253 | $322 | $297 |
| Other Inv. Act. | -$62 | $16 | $195 | $60 |
| Investing Cash Flow | -$62 | $16 | $195 | $59 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $329 | $3 | $2 | $155 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $335 | $4 | $2 | $6 |
| Financing Cash Flow | $335 | $4 | $2 | $6 |
| Forex Effect | $0 | -$0 | -$0 | $0 |
| Net Chg. in Cash | $129 | -$112 | $7 | -$64 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $130 | $243 | $236 | $299 |
| End Cash | $259 | $130 | $243 | $236 |
| Free Cash Flow | -$144 | -$132 | -$190 | -$130 |